Reclast for Paget's Disease

Browse eMedTV's wide range of articles related to reclast for paget's disease including topics such as reclast and pregnancy, reclast warnings and precautions, and reclast dosage. Use the search box at the top-right corner of the page to find information about other health topics.

Description of Articles in Reclast for Paget's Disease

Reclast is a drug used to help treat the breakdown of bone associated with Paget's disease and osteoporosis. This eMedTV segment provides a detailed look at the drug, including information on its effects, side effects, dosing guidelines, and more.

A few common Reclast side effects include joint pain, fever, and headache. This eMedTV Web page describes other side effects seen with the drug, including the ones that are less common and ones that should be reported immediately to your doctor.

Reclast, a bisphosphonate, is used to treat Paget's disease of the bone and osteoporosis. This segment of the eMedTV archives explains Reclast uses in detail, discussing off-label uses for the drug as well as whether it should be given to children.

The recommended Reclast dosage for Paget's disease of the bone is 5 mg. This eMedTV resource discusses Reclast dosing guidelines in detail and explains how the drug is given. Reclast dosing for osteoporosis is also discussed.

Reclast drug interactions can occur if it is combined with NSAIDs and diuretics, among other things. This eMedTV page lists other medicines that can interact with Reclast, describes the problems they can cause, and explains how they can be avoided.

This segment of the eMedTV Web site offers various Reclast warnings and precautions that you should be aware of before beginning treatment. This includes rare side effects to watch out for and conditions to tell your doctor about beforehand.

Although the exact effects of a Reclast overdose are unknown, as this eMedTV resource explains, it would likely affect the levels of certain minerals in the blood. Possible treatment options for an overdose are also described.

This eMedTV article takes a detailed look at Reclast and pregnancy. It describes the results of animal studies and explains why the FDA gave it a pregnancy Category D rating. Circumstances in which the drug may still be given are also described.

This page of the eMedTV Web site takes a look at the issues surrounding Reclast and breastfeeding. It explains the reasoning behind the manufacturer's recommendations and also stresses the importance of discussing it with your healthcare provider.

Generic Reclast is currently not available. This eMedTV resource explains why, describes what must happen for a generic version to become available, and also explains the difference between active ingredients in drugs and their generic names.